CDMO poacher turned biotech gamekeeper

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Vishnu Dwadasi, Director of Manufacturing at Ashvattha Therapeutics Inc.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Vishnu, covering:

• Lessons learned from 15 years in CDMOs and consulting, before joining a start-up drug development company
• What he’s learned from working with and managing CDMOs all over the world
• Why many CDMOs are behind the eight-ball... fancy marketing meets chaotic operations
• The challenge of scaling up through phases as a drug sponsor, and the evolving needs when it comes to outsourcing
• Major frustrations as a client in a post-covid world and the one area every CDMO needs to invest in moving forward

Vishnu Dwadasi is currently a Director of Manufacturing at a biopharmaceutical start-up company, Ashvattha Therapeutics, leading drug programs from pre-clinical to commercialization.

Vishnu brings over a decade of experience in life sciences with a unique background in pharmaceutical operations, consulting, and business development. He has developed extensive experience shepherding complex drug development programs from early clinical development to full-scale commercial manufacturing and distribution. Along with his drug development experience, Vishnu has gained expertise in operations and implementing technology solutions for life sciences companies.

Vishnu earned an MBA from Duke University and a B.S. in Health Sciences from Purdue University.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.